Ananda Developments Plc logo

Ananda Developments Plc (1FX)

Market Closed
3 Jun, 20:00
XSTU XSTU
0. 0005
0
0%
2.15M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
0.0005
Previous Close
Add Transaction
Day Range
0.0005 0.0005
Year Range
0.0005 0.0025
Want to track 1FX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1FX closed today higher at €0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 1FX stock lost -50%.
1FX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

1FX Chart

People also search for

5MX
Aspial Lifestyle Ltd.
0.01
0%
0E3
Cherrypick Games S.A.
1.5
0%
2UG
Ecc Games S.A.
0.04
-1.41%

Ananda Developments Plc (1FX) FAQ

What is the stock price today?

The current price is €0.0005.

On which exchange is it traded?

Ananda Developments Plc is listed on XSTU.

What is its stock symbol?

The ticker symbol is 1FX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.15M.

Has Ananda Developments Plc ever had a stock split?

No, there has never been a stock split.

Ananda Developments Plc Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Melissa Josephine Sturgess BSc, MBA CEO
XSTU Exchange
- ISIN
United Kingdom Country
9 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Ananda Developments Plc is a pioneering entity in the field of medicinal and therapeutic cannabis, focusing its efforts on the investment and development of solutions within this emerging market. Established in 2018 and headquartered in London, the United Kingdom, the company strives to leverage the therapeutic potentials of cannabinoids. Ananda Developments is dedicated to creating innovative cannabinoid-based medicines designed specifically to address chronic inflammatory pain conditions, an area of significant unmet medical need. Through its strategic investments and research initiatives, the company aims to be at the forefront of delivering effective, cannabis-based therapeutic options to patients, tapping into a market driven by increasing recognition of cannabis's medicinal benefits.

Products and Services

  • Cannabinoid-based Medicines:

Ananda Developments is focused on the discovery and development of medicines derived from cannabinoids. These medicines are intended for the treatment of chronic inflammatory pain conditions, providing an alternative to traditional pain management solutions. The company employs scientific methods to explore the efficacy and safety of cannabinoids, with the goal of producing pharmaceutical-grade products that meet rigorous medical standards.

Contact Information

Address: Huckletree Bishopsgate
Phone: -